“boehringer-ingelheim” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 05/06/20 National
Creating Consistent Value in Biotech Without Diluting Stakeholders 04/07/20 National
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug 10/31/19 Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer 06/19/19 San Diego
ResMed Boosts Connected Health Play With $225M Propeller Health Deal 12/03/18 Wisconsin
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M 10/29/18 Boston
Medisafe to Get Paid For Health App’s Performance 10/24/18 Boston
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals 08/03/18 Indiana
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines 06/11/18 Boston
Amgen Migraine Decision Looms, Maybe the Next Drug Price Fight, Too 05/16/18 National
Propeller, Express Scripts Partner to Monitor Asthma, COPD Patients 11/16/17 Wisconsin
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
Propeller CEO: Engagement, Environment Among Population Health Keys 05/04/17 Wisconsin
Page 1 of 3 next page »